New Delhi: The Production Linked Incentive (PLI) scheme, a pivotal component of the government’s AatmaNirbhar Bharat plan, is making significant strides in various sectors, boosting India’s manufacturing capabilities and promoting self-reliance. The PLI scheme for pharmaceuticals, an integral part of AatmaNirbhar Bharat, aims to enhance India’s manufacturing prowess and elevate its exports in the pharmaceutical sector.
In a similar vein, the PLI scheme for promoting domestic manufacturing of medical devices is strategically aligned with the goal of achieving self-sufficiency in specified target segments within the medical devices sector. This initiative is geared towards fostering a self-reliant India and reducing dependence on imports.
Recognizing the critical importance of enhancing domestic production in the pharmaceutical sector, the PLI scheme for critical Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (API) has been introduced. This move is expected to not only strengthen India’s manufacturing capabilities but also bolster exports, contributing to the nation’s economic growth.
Furthermore, with the vision of positioning India as a global drone hub by 2030, the PLI scheme for drones and drone components has been introduced. This initiative is anticipated to play a transformative role in boosting India’s manufacturing capabilities in the drone sector, creating substantial employment opportunities and fostering overall economic growth.
These PLI schemes underscore the government’s commitment to realizing the AatmaNirbhar Bharat vision, ensuring self-sufficiency, and positioning India as a global manufacturing powerhouse.